Ultragenyx Pharmaceutical (RARE) Net Margin Growth (5y) (2021 - 2026)
Ultragenyx Pharmaceutical (RARE) Net Margin Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.61 Bn | 2.33 Bn | 180.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9,777.00 |
| Mar 31, 2026 | 94.00 |
| Dec 31, 2025 | -23,985.00 |
| Sep 30, 2025 | -2,830.00 |
| Jun 30, 2025 | -11,006.00 |
| Mar 31, 2025 | 21,918.00 |
| Dec 31, 2024 | -94,393.00 |
| Sep 30, 2024 | 34,225.00 |
| Jun 30, 2024 | 32,116.00 |
| Mar 31, 2024 | 37,561.00 |
| Dec 31, 2023 | 44,293.00 |
| Sep 30, 2023 | 57,942.00 |
| Jun 30, 2023 | 26,456.00 |
| Mar 31, 2023 | -44,651.00 |
| Dec 31, 2022 | 53,293.00 |
| Sep 30, 2022 | 3.97 Mn |
| Dec 31, 2021 | 142.54 Mn |
| Sep 30, 2021 | 5.84 Mn |
| Jun 30, 2021 | 33.47 Mn |